Short recap:
At the end of last year, the MHRA announced that the implementation of the forthcoming UK medical device regulation and UKCA certification would be postponed by 12 months to July 2024. The statement said that manufacturers could continue to place CE marked medical devices on the market, in order to guarantee the continuous supply of medicines to UK patients (we reported). From July 2024, the transitional arrangement for the use of both CE and UKCA marked devices will then apply.
UKCA is the equivalent of the European CE marking, which is used to certify medical devices, among other things.
In the statement of 1 August 2023, the MHRA explicitly states that the UK Government's decision to support the indefinite recognition of CE marking for the time being does not apply to medical devices and in vitro diagnostic medical devices. For such products, the announced transition period from CE to UKCA marking shall be applicable as of 1 July 2024. By 2030 at the latest, CE marked medical devices are no longer to be approved. It states:
The current status and detailed information on the implementation of the stand-alone UK regulation can be found here.
Source:
Write a comment on this news.